Tatva Chintan Pharma Chem Limited (TATVA) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.00x

Tatva Chintan Pharma Chem Limited (TATVA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs131.66 Million. See Tatva Chintan Pharma Chem Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Rs0.00
Capex + Investments

Operating Cash Flow

Rs131.66 Million
INR

Capital Expenditures

Rs0.00
INR

Tatva Chintan Pharma Chem Limited Cash Flow Reinvestment Rate (2018–2025)

Historical reinvestment intensity for Tatva Chintan Pharma Chem Limited across 8 annual periods. For the full cash flow conversion analysis, see TATVA cash flow conversion.

Annual Cash Flow Reinvestment Rate for Tatva Chintan Pharma Chem Limited (2018–2025)

Year-by-year capital reinvestment analysis for Tatva Chintan Pharma Chem Limited. See Tatva Chintan Pharma Chem Limited free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2025 5.74x Rs1.42 Billion Rs246.71 Million Rs762.72 Million ▲ +125.8%
2024 2.54x Rs2.49 Billion Rs980.44 Million Rs1.29 Billion ▼ -76.8%
2023 10.95x Rs3.04 Billion Rs277.83 Million Rs2.03 Billion ▲ +10.8%
2022 9.88x Rs2.01 Billion Rs203.78 Million Rs891.57 Million ▲ +1032.8%
2021 0.87x Rs212.19 Million Rs243.19 Million Rs209.70 Million ▼ -60.3%
2020 2.20x Rs556.20 Million Rs253.12 Million Rs481.72 Million ▼ -4.9%
2019 2.31x Rs169.89 Million Rs73.56 Million Rs97.86 Million ▼ -21.1%
2018 2.93x Rs304.69 Million Rs104.12 Million Rs304.61 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow